|
RNF146 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.91119999998413E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.12280000039856E-07 |
| Normal-vs-Stage2 |
1.259160E-01 |
| Normal-vs-Stage3 |
3.342100E-02 |
| Normal-vs-Stage4 |
2.014300E-02 |
| Stage1-vs-Stage2 |
1.458630E-01 |
| Stage1-vs-Stage3 |
5.715600E-02 |
| Stage1-vs-Stage4 |
6.406800E-01 |
| Stage2-vs-Stage3 |
9.429600E-01 |
| Stage2-vs-Stage4 |
4.251800E-01 |
| Stage3-vs-Stage4 |
3.687800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.196900E-04 |
| Normal-vs-AfricanAmerican |
1.620010E-02 |
| Normal-vs-Asian |
1.52559999999635E-05 |
| Caucasian-vs-AfricanAmerican |
1.729380E-01 |
| Caucasian-vs-Asian |
1.689910E-02 |
| AfricanAmerican-vs-Asian |
7.432400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.012490E-04 |
| Normal-vs-Female |
6.46089999999377E-05 |
| Male-vs-Female |
2.660400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62057999999465E-05 |
| Normal-vs-Age(41-60Yrs) |
1.962400E-04 |
| Normal-vs-Age(61-80Yrs) |
5.156100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.712600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.555800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.928500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.748400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.278600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.288800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.672800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.027600E-04 |
| Classical-VS-Follicular |
6.097400E-01 |
| Classical-VS-Other |
8.646800E-01 |
| Classical-VS-Normal |
3.79970000019547E-07 |
| Tall-VS-Follicular |
4.346500E-02 |
| Tall-VS-Other |
1.352750E-01 |
| Tall-VS-Normal |
8.376200E-01 |
| Follicular-VS-Other |
9.469400E-01 |
| Follicular-VS-Normal |
1.401790E-02 |
| Other-VS-Normal |
5.036400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.160010E-04 |
| Normal-vs-N1 |
9.037700E-03 |
| N0-vs-N1 |
7.093600E-01 |
|
|
